BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Worland T, Hey P, Wong D, Apostolov R, Chan RK, Sinclair M, Gow P. Rifaximin-α use is associated with improved muscle mass in patients with cirrhosis. World J Hepatol 2025; 17(4): 104056 [PMID: 40308826 DOI: 10.4254/wjh.v17.i4.104056]
URL: https://www.wjgnet.com/1948-5182/full/v17/i4/104056.htm
Number Citing Articles
1
Mohamed El-Kassas, Khalid AlNaamani. Rifaximin and sarcopenia in cirrhosis: Commentary on a promising but complex relationshipWorld Journal of Hepatology 2025; 17(9): 108951 doi: 10.4254/wjh.v17.i9.108951